Dear Well-wishers,

I pen this November 2018 edition of Oviya MedSafe‘s newsletter with an extra dose of fervour, thanks to a couple of new accolades the organization was honoured with at New Delhi during the month!

On 15th November 2018, Germany-based Lumis International organized a conference titled ‘Clinical Research in Europe: What you need to know to successfully enter the EU Market?’ at India International Centre, New Delhi. The conference which was meant for pharmaceutical companies that intend to introduce their products in Europe had Germany-based eMQT, Netherlands-based Salvius and Oviya MedSafe as co-organizers. The coming together of Oviya MedSafe with these three organizations was facilitated not only by our lines of businesses which complement each other but more so by the professional camaraderie I share with the my counterpart founders Heike Schoen (Lumis), Myrthe Trompert (Salvius) and Nancy Meyerson-Hess (eMQT).

Heike, Myrthe and Nancy spoke on the RegulatoryLegal and Quality modules respectively. I took up the module on Drug Safety and Pharmacovigilance, in which I emphasized on the requirements for post-approval monitoring of product safety in Europe. The high point of the conference was the participation of Dr G N Singh, Secretary cum Scientific Director of the Indian Pharmacopoeia Commission (IPC) as the Chief Guest and Prof Bejon Misra, International Consumer Policy Expert as the Guest of Honour. During their keynote addresses, both the dignitaries shared their perspectives on the need for developing more expertise in Clinical Research and expressed their desire for fostering further collaborative ventures between the West and the East in this domain. Dr V Kalaiselvan and Dr Jai Prakash from IPC accompanied Dr G N Singh. Pictures clicked at the conference may be viewed and/or downloaded from this link.

The bigger occasion of special recognition for Oviya MedSafe was on 16th November 2018 when I was invited to share my entrepreneurial experiences in Pharmacovigilance with aspiring entrepreneurs at the 1st Entrepreneur Development Programme on Pharmacopoeial and Pharmacovigilance Services organized by the Start-Up Cell of IPC at their office in Ghaziabad. The programme was inaugurated by Dr G N Singh and had dignitaries and other speakers from the CDSCO and the pharmaceutical industry apart from IPC. Being the only Pharmacovigilance entrepreneur invited by the Government of India to speak at the very first event of its kind, it was one of the greatest privileges not only for me but more so for Oviya MedSafe. I wish to dedicate this glory to my wonderful team members without whom Oviya MedSafe would not have reached this stage of being seen as a “Lighthouse of Pharmacovigilance” for the future generations of ‘Pharmacovigilantes‘. To view/download photos clicked at the event, please visit this URL.

Before signing off, I would like to invite you all to register for the three-day 12th Annual Conference of the Indian Society for Clinical Research (ISCR) at New Delhi in which I will be the Workshop Lead of the pre-conference workshop ‘How the New Pharmacovigilance Obligations for MAHs in India may be fulfilled‘ that is scheduled to be held on 14th February 2019. Registration for the pre-conference workshop can be done separately or in combination with the registration for the whole conference.

Looking forward to connecting with you in December 2018,

With thanks & regards,
Dr J Vijay Venkatraman

Managing Director & CEO,
Oviya MedSafe Pvt Ltd,
Coimbatore, India
Phone: +91-422-2444442

Oviya MedSafe UK Ltd,
London, UK
Phone: +44-8452-733839

Follow us on: FacebookLinkedIn & Twitter

Leave a comment

Your email address will not be published. Required fields are marked *